跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 34,897 条关于
“New England Biolabs”
全部
34,897
临床试验
9,047
药物
321
机构
377
资讯
25,152
6个月前
New England Biolabs and Touchlight Launch Cell-Free DNA Synthesis Kit to Accelerate Gene Therapy Development
上个月
mRNA Synthesis Raw Materials Market to Surpass USD 3.89 Billion by 2035
去年
Infigratinib Shows Promise in Phase 2 Trial for Children with Achondroplasia
上个月
Epigenomics Market Poised to Reach $69.6 Billion by 2034 on 15.2% CAGR, Driven by Oncology and Precision Medicine
去年
NHS England Fast-Tracks Quizartinib for FLT3-ITD Positive Acute Myeloid Leukemia
去年
Genentech's Itovebi Demonstrates Significant Overall Survival Benefit in PIK3CA-Mutated Breast Cancer
去年
Genentech's Itovebi Combo Demonstrates Overall Survival Benefit in HER2-Negative Breast Cancer
去年
Roche's Itovebi Plus Palbociclib and Fulvestrant Significantly Improves Progression-Free Survival in PIK3CA-Mutated Breast Cancer
去年
Roche's Itovebi Demonstrates Landmark Progression-Free Survival in HR-positive Breast Cancer
去年
Infigratinib Shows Promise in Phase 2 Trial for Achondroplasia
第 1 页,共 2516 页
上一页
下一页